Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

Abroad (travel likely)Recruiting

Conditions

Pneumococcal Vaccine · Esophageal Cancer · Lymphopenia · Chemoradiation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Steven H Lin, MD) · shlin@mdanderson.org · 713-563-8490

Study leads

Steven H Lin, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses

Aging

Abroad (travel likely)RecruitingPHASE4

Buffalo, United States

Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines

Vaccine · Pneumococcal Disease

Abroad (travel likely)RecruitingPHASE4

Birmingham, United States

Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma

Vaccine · Streptococcus Pneumoniae · Lymphoma, Non-Hodgkin

Abroad (travel likely)RecruitingPHASE4

Angers, France · Bordeaux, France

A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine

Pneumococcal Vaccines · Pneumococcal Infections

Abroad (travel likely)RecruitingPHASE3

Denpasar, Indonesia · Bandung, Indonesia